SCHEMBL4679440

SCHEMBL4679440

CCN(CC1CCN(C(=O)NC(C)C)CC1)C(C)Cc1ccc(OC)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PSMB8 P28062 6/20 0.43
PSMB5 P28074 6/20 0.43
PSMB9 P28065 1/20 0.43
MMP1 P03956 1/20 0.43
MMP13 P45452 1/20 0.43
TSHR P16473 3/20 0.42
CYP2D6 P10635 2/20 0.41
HRH3 Q9Y5N1 2/20 0.41
MCHR1 Q99705 1/20 0.41
CALCRL Q16602 1/20 0.41
DPP4 P27487 1/20 0.40
FAP Q12884 1/20 0.40
DPP8 Q6V1X1 1/20 0.40
DPP9 Q86TI2 1/20 0.40
DPP7 Q9UHL4 1/20 0.40
ADRB2 P07550 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4685664 0.91 SMN1; SMN2 (0.44) MEN1KMT2ASMN1; SMN2PSMB8PSMB5
SCHEMBL4739666 0.88 MMP1 (0.43) MEN1KMT2ASMN1; SMN2PSMB8PSMB5
Hydrochloric Acid SCHEMBL4679238 0.88 CYP3A4 (0.43) MEN1KMT2ASMN1; SMN2MMP1MMP13
SCHEMBL4680567 0.87 CYP2D6 (0.45) MEN1KMT2ASMN1; SMN2TSHRCYP2D6
SCHEMBL4678547 0.87 CYP2D6 (0.43) MEN1KMT2ASMN1; SMN2TSHRCYP2D6
Hydrochloric Acid SCHEMBL4683782 0.86 CYP3A4 (0.43) MEN1KMT2ASMN1; SMN2TSHRCYP2D6
Hydrochloric Acid SCHEMBL4683142 0.86 MMP1 (0.44) MEN1KMT2ASMN1; SMN2MMP1MMP13
Hydrochloric Acid SCHEMBL4685539 0.84 ALDH1A1 (0.45) MEN1KMT2ASMN1; SMN2MMP1MMP13
Hydrochloric Acid SCHEMBL4685543 0.84 ALDH1A1 (0.45) MEN1KMT2ASMN1; SMN2MMP1MMP13
SCHEMBL4682805 0.83 ALDH1A1 (0.50) SMN1; SMN2MMP1MMP13GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1058680-B1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 EP disclosed
US-6319920-B1 MUSCARINIC RECEPTOR ANTAGONIST USED IN GASTROINTESTINAL, GENITOURINARY TRACT, RESPIRATORY TRACT, CARDIOVASCULAR SYSTEM, CENTRAL NERVOUS SYSTEM DISORDERS AND IN ANESTHESIOLOGY AND OPHTHALMOLOGY SYNTEX (U.S.A.) LLC 2001-11-20 US disclosed
EP-1058680-A1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2000-12-13 EP disclosed
WO-1999043657-A1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1999-09-02 WO disclosed